USD 0.48
(-0.17%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 8.5 Million USD | -15.67% |
2022 | 10.08 Million USD | 232.97% |
2021 | 3.03 Million USD | 461.11% |
2020 | 540 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 9.24 Million USD | 8.67% |
2024 Q2 | 6.74 Million USD | -27.03% |
2023 FY | 8.5 Million USD | -15.67% |
2023 Q3 | 10.63 Million USD | 22.49% |
2023 Q1 | 10.31 Million USD | 2.2% |
2023 Q4 | 8.5 Million USD | -20.02% |
2023 Q2 | 8.68 Million USD | -15.78% |
2022 Q4 | 10.08 Million USD | -2.72% |
2022 Q3 | 10.37 Million USD | 11.41% |
2022 Q1 | - USD | -100.0% |
2022 Q2 | 9.3 Million USD | 0.0% |
2022 FY | 10.08 Million USD | 232.97% |
2021 Q1 | - USD | -100.0% |
2021 FY | 3.03 Million USD | 461.11% |
2021 Q2 | 961 Thousand USD | 0.0% |
2021 Q4 | 3.03 Million USD | 0.0% |
2020 Q4 | 540 Thousand USD | 0.0% |
2020 Q3 | 540 Thousand USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 540 Thousand USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Journey Medical Corporation | 10.2 Million USD | 16.637% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 92.349% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -25.691% |
Pacira BioSciences, Inc. | 104.35 Million USD | 91.847% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -48.359% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -48.359% |
SCYNEXIS, Inc. | - USD | -Infinity% |
Safety Shot Inc | 1.86 Million USD | -355.059% |
Alpha Teknova, Inc. | 11.59 Million USD | 26.617% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 73.686% |
Bright Green Corporation | - USD | -Infinity% |
Dynavax Technologies Corporation | 53.29 Million USD | 84.035% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 87.035% |
Cosmos Health Inc. | 4.78 Million USD | -77.655% |
PainReform Ltd. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -950.686% |
Embecta Corp. | 152.1 Million USD | 94.406% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 26.951% |
Procaps Group, S.A. | 96.83 Million USD | 91.214% |
Theratechnologies Inc. | 6.06 Million USD | -40.257% |
Harrow Health, Inc. | 10.86 Million USD | 21.708% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -212.909% |
Biofrontera Inc. | 10.9 Million USD | 22.002% |
DURECT Corporation | 2.21 Million USD | -283.416% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 89.009% |
Cronos Group Inc. | 30.33 Million USD | 71.957% |
OptiNose, Inc. | 8.05 Million USD | -5.663% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -850799900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -49.288% |
Organogenesis Holdings Inc. | 28.25 Million USD | 69.886% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -217.805% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -84.581% |
Radius Health, Inc. | 278.64 Million USD | 96.947% |
Universe Pharmaceuticals INC | 3.34 Million USD | -154.482% |
ProPhase Labs, Inc. | 3.84 Million USD | -121.505% |
Phibro Animal Health Corporation | 265.91 Million USD | 96.8% |
Procaps Group S.A. | 96.83 Million USD | 91.214% |
Alvotech | 74.43 Million USD | 88.57% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.755% |
Rockwell Medical, Inc. | 5.87 Million USD | -44.916% |
Aytu BioPharma, Inc. | 12.63 Million USD | 32.653% |
SIGA Technologies, Inc. | 64.21 Million USD | 86.751% |
Tilray Brands, Inc. | 252.08 Million USD | 96.625% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 78.719% |
Shineco, Inc. | 1.58 Million USD | -435.591% |
PetIQ, Inc. | 159.3 Million USD | 94.659% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 5668.865% |
Incannex Healthcare Limited | -10.01 Million USD | 184.953% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 77.786% |
Alimera Sciences, Inc. | 1.87 Million USD | -352.794% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 77.424% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -428.319% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -89.784% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -3244.971% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 18.035% |
Hempacco Co., Inc. | 2.54 Million USD | -234.614% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 88.57% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 82.199% |
Lantheus Holdings, Inc. | 64.02 Million USD | 86.712% |
Currenc Group, Inc. | 732.91 Thousand USD | -1060.85% |
Kamada Ltd. | 87.74 Million USD | 90.304% |
Indivior PLC | 141.79 Million USD | 94.0% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -1665.731% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -3244.971% |
Evolus, Inc. | 10.99 Million USD | 22.64% |
HUTCHMED (China) Limited | 50.25 Million USD | 83.071% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 91.961% |
Akanda Corp. | 1.28 Million USD | -561.127% |